Related Experiment Video
Updated: May 26, 2026

Differentiation and Characterization of Neural Progenitors and Neurons from Mouse Embryonic Stem Cells
Published on: May 15, 2020
Stepwise renal lineage differentiation of mouse embryonic stem cells tracing in vivo development
Masaki Nishikawa1, Naomi Yanagawa, Nobuhiko Kojima
1Medical and Research Services, Greater Los Angeles Veterans Affairs Healthcare System at Sepulveda, North Hills, CA 91343, USA. masakiwestriver@gmail.com
Abstract:
The in vitro derivation of renal lineage progenitor cells is essential for renal cell therapy and regeneration. Despite extensive studies in the past, a protocol for renal lineage induction from embryonic stem cells remains unestablished. In this study, we aimed to induce renal lineages from mouse embryonic stem cells (mESC) by following in vivo developmental stages, i.e., the induction of mesoderm (Stage I), intermediate mesoderm (Stage II) and renal lineages (Stage III). For stage I induction, in accordance with known signaling pathways involved in mesoderm development in vivo, i.e., Nodal, bone morphogenic proteins (BMPs) and Wnt, we found that the sequential addition of three factors, i.e., Activin-A (A), a surrogate for Nodal signaling, during days 0-2, A plus BMP-4 (4) during days 2-4, and A4 plus lithium (L), a surrogate for Wnt signaling, during days 4-6, was most effective to induce the mesodermal marker, Brachyury. For stage II induction, the addition of retinoic acid (R) in the continuous presence of A4L during days 6-8 was most effective to induce nephrogenic intermediate mesodermal markers, such as Pax2 and Lim1. Under this condition, more than 30% of cells were stained positive for Pax2, and there was a concomitant decrease in the expression of non-mesodermal markers. For stage III induction, in resemblance to the reciprocal induction between ureteric bud (UB) and metanephric mesenchyme (MM) during kidney development, we found that the exposure to conditioned media derived from UB and MM cells was effective in inducing MM and UB markers, respectively. We also observed the emergence and gradual increase of cell populations expressing progenitor cell marker CD24 from Stage I to Stage III. These CD24(+) cells correlated with higher levels of expression of Brachyury at stage I, Pax2 and Lim1 at stage II and MM markers, such as WT1 and Cadherin 11, after exposure to UB-conditioned media at stage III. In conclusion, our results show that stepwise induction by tracing in vivo developmental stages was effective to generate renal lineage progenitor cells from mESC, and CD24 may serve as a useful surface marker for renal lineage cells at stage II and MM cells at stage III.
Insights
Researchers developed a new protocol to generate renal progenitor cells from mouse embryonic stem cells (mESC). This method mimics in vivo development, offering a promising avenue for renal cell therapy and regeneration research.
Area of Science:
- Stem Cell Biology
- Developmental Biology
- Regenerative Medicine
Background:
- Generating renal lineage progenitor cells in vitro is crucial for advancing renal cell therapy and regeneration.
- Existing protocols for inducing renal lineages from embryonic stem cells are not yet established.
Purpose of the Study:
- To establish a protocol for inducing renal lineages from mouse embryonic stem cells (mESC) by mimicking in vivo developmental stages.
- To identify key signaling pathways and factors for mesoderm, intermediate mesoderm, and renal lineage induction.
Main Methods:
- Sequential addition of signaling molecules (Activin-A, BMP-4, Lithium) to mimic embryonic development stages.
- Utilized retinoic acid and conditioned media from ureteric bud (UB) and metanephric mesenchyme (MM) cells for lineage induction.
- Monitored expression of key developmental markers (Brachyury, Pax2, Lim1, WT1, Cadherin 11) and progenitor cell marker CD24.
Main Results:
- Successfully induced mesoderm (Stage I) using Activin-A, BMP-4, and Lithium, evidenced by Brachyury expression.
- Induced nephrogenic intermediate mesodermal markers (Pax2, Lim1) (Stage II) with retinoic acid.
- Achieved induction of metanephric mesenchyme (MM) and ureteric bud (UB) markers (Stage III) using conditioned media, with CD24 identified as a potential progenitor cell marker.
Conclusions:
- Stepwise induction mimicking in vivo development effectively generates renal lineage progenitor cells from mESC.
- CD24 is a potential surface marker for identifying renal lineage cells at Stage II and MM cells at Stage III.
- This protocol provides a foundation for future renal cell therapy and regenerative strategies.

